Danaher Corporation is a global company based in Washington, DC, United States. It designs, manufactures, and markets a wide range of professional, medical, industrial, and commercial products and services. The company operates in several sectors, including Diagnostics & Research, Healthcare, Life Sciences, and Environmental & Applied Solutions.
In the Diagnostics segment, Danaher provides various systems and products for chemistry, immunoassay, microbiology, and automation, catering to hospitals, physicians' offices, and reference laboratories. The Life Sciences segment offers mass spectrometers, genomics tools, flow cytometry, lab automation, and other products to pharmaceutical, biopharmaceutical, medical, and life sciences companies.
The Environmental & Applied Solutions segment provides instruments, software, services, and disinfection systems for water analysis, treatment, and management, along with solutions for color and appearance management, packaging design, and quality control in consumer, pharmaceutical, and industrial sectors.
The company was founded in 1969 and was previously known as Diversified Mortgage Investors before changing its name to Danaher Corporation in 1984. It has approximately 79,000 full-time employees. The company's website is [https://www.danaher.com](https://www.danaher.com).
Key financial information includes a market capitalization of $173.68 billion, a dividend rate of $1.08 with a yield of 0.46%, and a trailing price-to-earnings ratio of 25.34. The stock is traded on the NYSE under the ticker symbol "DHR." Analysts generally recommend buying the stock, with a target mean price of $276.57.
+--------------------------------------------+--------------+ | Financial Measure | Value | +============================================+==============+ | EPS | 9.29 | +--------------------------------------------+--------------+ | Trailing Price to Earnings Ratio | 25.3358 | +--------------------------------------------+--------------+ | Price to Book Ratio | 3.44572 | +--------------------------------------------+--------------+ | Dividend Yield (%) | 0.46 | +--------------------------------------------+--------------+ | Return On Equity (%) | 14.173 | +--------------------------------------------+--------------+ | Debt to Equity Ratio | 40.656 | +--------------------------------------------+--------------+ | Free Cash Flow (in million dollars) | 5879.63 | +--------------------------------------------+--------------+ | Market Capitalization (in million dollars) | 173679 | +--------------------------------------------+--------------+ | Revenue Growth (%) | -6.8 | +--------------------------------------------+--------------+ | Operating Margin (%) | 27.018 | +--------------------------------------------+--------------+ | Forward Price to Earnings Ratio | 22.6753 | +--------------------------------------------+--------------+
Financial Measure Percentile Stock 0 EPS 68.686869 1 P/E Ratio 56.250000 2 P/B Ratio 38.461538 3 Dividend Yield (%) 3.571429 4 Return On Equity 41.111111 5 Debt to Equity 17.857143 6 Free cash Flow (in million) 52.873563 7 Market Cap (in million) 61.000000 8 Revenue Growth 17.346939 9 Operating Margin 63.265306 10 Total 420.423898
The percentile rankings of financial measures of Danaher Corporation (DHR) compared to S&P 100 stocks are as follows:
1. EPS: DHR's EPS percentile is 68.69, indicating that its earnings per share performance is better than approximately 68.69% of S&P 100 stocks.
2. P/E Ratio: DHR's P/E ratio percentile is 56.25, suggesting that its price-to-earnings ratio is lower than approximately 56.25% of S&P 100 stocks.
3. P/B Ratio: DHR's P/B ratio percentile is 38.46, showing that its price-to-book ratio is lower than approximately 38.46% of S&P 100 stocks.
4. Dividend Yield (%): DHR's dividend yield percentile is 3.57, indicating that its dividend yield is higher than approximately 3.57% of S&P 100 stocks.
5. Return On Equity: DHR's return on equity percentile is 41.11, suggesting that its return on equity is higher than approximately 41.11% of S&P 100 stocks.
6. Debt to Equity: DHR's debt-to-equity ratio percentile is 17.86, indicating that its debt-to-equity ratio is lower than approximately 17.86% of S&P 100 stocks.
7. Free Cash Flow (in million): DHR's free cash flow percentile is 52.87, suggesting that its free cash flow is higher than approximately 52.87% of S&P 100 stocks.
8. Market Cap (in million): DHR's market capitalization percentile is 61.00, indicating that its market capitalization is higher than approximately 61.00% of S&P 100 stocks.
9. Revenue Growth: DHR's revenue growth percentile is 17.35, suggesting that its revenue growth rate is lower than approximately 17.35% of S&P 100 stocks.
10. Operating Margin: DHR's operating margin percentile is 63.27, indicating that its operating margin is higher than approximately 63.27% of S&P 100 stocks.
Overall, based on these percentiles, DHR performs well in terms of EPS, P/E ratio, return on equity, debt to equity ratio, and operating margin compared to the S&P 100 stocks. However, its performance in terms of P/B ratio, dividend yield, revenue growth, and market capitalization is relatively average compared to the S&P 100 stocks.
No comments:
Post a Comment